S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NYSEAMERICAN:INFU

InfuSystem (INFU) Stock Price, News & Analysis

$8.63
-0.17 (-1.93%)
(As of 03/28/2024 ET)
Today's Range
$8.55
$8.82
50-Day Range
N/A
52-Week Range
$7.45
$11.44
Volume
44,560 shs
Average Volume
42,096 shs
Market Capitalization
$182.78 million
P/E Ratio
287.76
Dividend Yield
N/A
Price Target
N/A
INFU stock logo

About InfuSystem Stock (NYSEAMERICAN:INFU)

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

INFU Stock Price History

INFU Stock News Headlines

InfuSystem Holdings Inc
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Q4 2023 InfuSystem Holdings Inc Earnings Call
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
InfuSystem Holdings: 2024 Will Be A Year Of Monetization
Analysts’ Top Healthcare Picks: EDAP TMS (EDAP), DermTech (DMTK)
InfuSystem Q3 2023 Earnings Preview
See More Headlines
Receive INFU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:INFU
Employees
420
Year Founded
N/A

Profitability

Net Income
$870,000.00
Pretax Margin
1.36%

Debt

Sales & Book Value

Annual Sales
$125.79 million
Cash Flow
$0.66 per share
Book Value
$2.32 per share

Miscellaneous

Free Float
17,265,000
Market Cap
$182.78 million
Optionable
Not Optionable
Beta
1.26
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Richard A. DiIorio (Age 49)
    CEO & Director
    Comp: $806.26k
  • Ms. Carrie A. Lachance B.S.N. (Age 47)
    M.B.A., R.N., President, COO & Director
    Comp: $473.54k
  • Mr. Barry G. Steele (Age 53)
    Executive VP & CFO
    Comp: $303.33k
  • Mr. Addam Chupa (Age 45)
    Executive VP & Chief Information Officer
  • Jerod Funke
    Executive VP & Chief HR Officer
  • Jeanie Latz
    Corporate Secretary

INFU Stock Analysis - Frequently Asked Questions

Are investors shorting InfuSystem?

InfuSystem saw a increase in short interest in February. As of February 29th, there was short interest totaling 270,600 shares, an increase of 14.6% from the February 14th total of 236,100 shares. Based on an average daily volume of 41,500 shares, the days-to-cover ratio is currently 6.5 days. Approximately 1.5% of the shares of the company are short sold.
View InfuSystem's Short Interest
.

How were InfuSystem's earnings last quarter?

InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) announced its quarterly earnings data on Monday, November, 15th. The medical instruments supplier reported ($0.02) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.03 by $0.05. The medical instruments supplier had revenue of $26.57 million for the quarter, compared to analyst estimates of $28 million. InfuSystem had a net margin of 0.69% and a trailing twelve-month return on equity of 1.75%.

What other stocks do shareholders of InfuSystem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InfuSystem investors own include Macquarie Infrastructure (MIC), Second Sight Medical Products (EYES), Otelco (OTEL), Pershing Gold (PGLC), Palatin Technologies (PTN), AgroFresh Solutions (AGFS), Advanced Micro Devices (AMD) and Digital Turbine (APPS).

Who are InfuSystem's major shareholders?

InfuSystem's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (5.03%), Vanguard Group Inc. (5.03%), Meros Investment Management LP (4.17%), Wasatch Advisors LP (4.00%), Ranger Investment Management L.P. (3.26%) and First Eagle Investment Management LLC (2.54%). Insiders that own company stock include Carrie Lachance, Christopher R Sansone, Gregg Owen Lehman, Jeannine Sheehan, Kevin Whitman, Paul Andrew Gendron, R Rimmy Malhotra, Richard Dilorio and Thomas Mark Ruiz.
View institutional ownership trends
.

How do I buy shares of InfuSystem?

Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:INFU) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners